This analysis identifies myelin alterations in Alzheimer’s model using MRI and X-ray scattering, suggesting improved measurement techniques.
Motivation: Myelin's involvement in Alzheimer's is unclear, partially due to lack of quantitative measurements. X-ray scattering can quantify myelin tomographically and validate myelin MRI. Goal(s): Probe myelin changes in AD mice using diffusion MRI and X-ray scattering. Approach: We used advanced diffusion and X-ray scattering to examine myelin changes in AD vs controls. After registration to Allen Atlas, we examined key white matter (corpus callosum/fornix/alveus) and gray matter areas (cortex/hippocampus/thalamus). Results: In white matter, we observed diffusion and X-ray changes consistent with decreased myelin in AD mice. In gray matter, X-ray sensitively captured myelin changes not captured by diffusion. Impact: We show the combined application of X-ray scattering and MRI to probe myelin changes in the white and gray matter of an AD mouse model. X-ray scattering can help validate MRI and quantify myelin changes in neurodegenerative diseases.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: